Rheumatoid Arthritis Trial, Recruiting (NCT05062421)

Rheumatoid Arthritis Trial, Recruiting NCT05062421 Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Condition: Rheumatoid Arthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05062421 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rheumatoid Arthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older.
You must have been diagnosed with Adult Rheumatoid Arthritis based on specific 2010 medical guidelines (confirm with trial site).
You must have already received at least one dose of the medications being studied in this trial.
You must be a patient currently being followed up at the Rheumatology department of the HUVM hospital.
You must have had at least two full check-up assessments recorded — one at the start and one at the end of the study period.

Who may not be able to join:

You may not be eligible if your medical records do not contain enough information about your health at the start and end of the study to be used in the analysis.
You may not be eligible if more than half of the required information about you is missing from your records.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Blanca Estela Hernández Cruz, Hospital Universitario Virgen Macarena

Phone: 955008000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05062421

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Phase: Not Applicable

Status: Recruiting

Condition: Rheumatoid Arthritis

Trial contact: 955008000

More information: https://clinicaltrials.gov/study/NCT05062421

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older.
You must have been diagnosed with Adult Rheumatoid Arthritis based on specific 2010 medical guidelines (confirm with trial site).
You must have already received at least one dose of the medications being studied in this trial.
You must be a patient currently being followed up at the Rheumatology department of the HUVM hospital.
You must have had at least two full check-up assessments recorded — one at the start and one at the end of the study period.

Who may not be able to join:

You may not be eligible if your medical records do not contain enough information about your health at the start and end of the study to be used in the analysis.
You may not be eligible if more than half of the required information about you is missing from your records.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Registry

ClinicalTrials.gov

Start date

1 April 2021

Est. completion

1 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Survival study

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov